AI Article Synopsis
- The study examines the restoration process of the hemopoietic microenvironment in the spleen after partial damage, looking at both function and structure.
- The restoration occurs locally within the damaged area and is primarily influenced by the properties of the spleen's stroma.
- This process is unaffected by the broader regeneration conditions, whether the damage occurs in the original location or through transplantation to another site.
Article Abstract
The initial stages of restoration of hemopoietic microenvironment in a regenerating spleen were studied functionally and morphologically after its partial damage. The hemopoietic microenvironment is restored locally and this process involves the damaged region only. The stages of restoration of hemopoietic microenvironment in the spleen are determined only by the properties of the spleen stroma itself and do not depend on the conditions of regeneration (in situ damage or ectopic transplantation).
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
VISTA in hematological malignancies: a review of the literature.
Front Immunol
January 2025
Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
In recent years, tumor immunotherapy has become an active research area, with the emergence of immune checkpoint inhibitors (ICIs) revolutionizing immunotherapy. Clinical evidence indicates that programmed cell death protein 1 (PD-1) monoclonal antibodies and other drugs have remarkable therapeutic effects. V-domain Ig suppressor of T-cell activation (VISTA) is a new type of immune checkpoint receptor that is highly expressed in various tumors.
View Article and Find Full Text PDFComputing cell state discriminates the aberrant hematopoiesis and activated microenvironment in Myelodysplastic syndrome (MDS) through a single cell genomic study.
J Transl Med
July 2024
Department of Hematology, Tianjin Medical University Tianjin General Hospital, Tianjin, China.
Background: Myelodysplastic syndrome (MDS) is a complicated hematopoietic malignancy characterized by bone marrow (BM) dysplasia with symptoms like anemia, neutropenia, or thrombocytopenia. MDS exhibits considerable heterogeneity in prognosis, with approximately 30% of patients progressing to acute myeloid leukemia (AML). Single cell RNA-sequencing (scRNA-seq) is a new and powerful technique to profile disease landscapes.
View Article and Find Full Text PDF[Clinical significance of IL-18 and IL-18-binding protein in bone marrow of patients with myelodysplastic syndrome].
Zhonghua Xue Ye Xue Za Zhi
March 2024
Department of Hematology, General Hospital of Tianjin Medical University, Tianjin 300052, China Tianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, Tianjin 300052, China.
Article Synopsis
- The study examines the levels of IL-18 and IL-18-binding protein (BP) in the bone marrow of 43 patients newly diagnosed with myelodysplastic syndrome (MDS) and compares these levels to control groups with acute myeloid leukemia (AML) and iron-deficiency anemia (IDA).
- Findings reveal that levels of IL-18, IL-18 BP, and free IL-18 are significantly higher in MDS patients compared to those with IDA, with free IL-18 levels showing a negative correlation to the MDS severity score (IPSS).
- The research suggests that IL-18 BP may reduce free IL-18 levels and impact the functionality of CD8(+) T cells, indicating that
HERVs may perform as the initial trigger for acquired aplastic anemia.
J Transl Med
March 2024
Department of Hematology, Tianjin Medical University General Hospital, No.154 Anshan Road, Heping District, Tianjin, 300052, China.
Monocytes in allo-HSCT with aged donors secrete IL-1/IL-6/TNF to increase the risk of GVHD and damage the aged HSCs.
iScience
March 2024
Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Aging is considered a critical factor of poor prognosis in allogenic hemopoietic stem cell transplantation (allo-HSCT). To elucidate the underlying mechanisms, we comprehensively reintegrated our clinical data from patients after allo-HSCT and public single-cell transcriptomic profile from post-allo-HSCT and healthy individuals, demonstrating that old donors were more prone to acute GVHD (aGVHD) with pronounced inflammation accumulation and worse overall survival (OS). We also found the presence of inflammation-related CXCL2+ HSC subpopulation during aging with significantly enriched pro-inflammatory pathways.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!